Publication: SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
No Thumbnail Available
Identifiers
Date
2022-05-05
Authors
Ciruelos, E. M.
Ponce, J.
Pernas Simon, S.
Cortes, J.
Cantos, B.
Garate, E.
Vega Alonso, E.
Mele Olive, M.
Martinez De Duenas, E.
Montano Perianez, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
